2m 2m 2m 2m 2m 2m 2m
Ultragenyx Pharm (RARE)
NASDAQ
$33.53+$0.30 (+0.92%)
Price as of Jul 14, 2026 4:50 AM EDT- $3.3BMarket Cap
- 13.65%1-Year Change
- BiotechnologyIndustry
Ultragenyx Pharm (RARE)
$33.53+$0.30 (+0.92%)
RARE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $33.22 | ||
Change | -$0.60 (-1.77%) | ||
Open | $33.06 | ||
High | $33.30 | ||
Low | $31.81 | ||
Previous Close | $33.82 | ||
Volume | 1,394,276 | ||
30-Day Average Volume | 3,392,071 | ||
1-Week Change | -1.42% | ||
1-Month Change | 36.43% | ||
1-Year Change | 13.65% | ||
3-Year Change | -24.79% | ||
5-Year Change | -62.06% | ||
Fundamentals | |||
Shares Outstanding | 98.5M | ||
Total Assets | $1.3B | ||
Market Cap | $3.3B | ||
Enterprise Value | $3.2B | ||
Period: QTR TTM FY | |||
Revenue | $89.0M | ||
Net Income | -$185.0M | ||
Free Cash Flow | -$198.0M | ||
EBIT | -$184.0M | ||
EBITDA | -$176.0M | ||
Net Working Capital | $332.0M | ||
EPS | -$1.84 | ||
Enterprise Value/EBITDA | -18 | ||
Enterprise Value/Revenue | 35 | ||
P/B | -14 | ||
P/E | -18 | ||
PEG | 0 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue